Klisyri

— THERAPEUTIC CATEGORIES —
  • Actinic keratoses

Klisyri Generic Name & Formulations

General Description

Tirbanibulin 1%; oint.

Pharmacological Class

Microtubule inhibitor.

How Supplied

Single-dose packets—5

Manufacturer

Generic Availability

NO

Klisyri Indications

Indications

Actinic keratosis on the face or scalp.

Klisyri Dosage and Administration

Adult

≥18yrs: Apply sufficient amount to cover up to 25cm2 area on the face or scalp once daily for 5 days (1 packet per application). Avoid washing and touching treated area for approx. 8hrs.

Children

<18yrs: not established.

Klisyri Contraindications

Not Applicable

Klisyri Boxed Warnings

Not Applicable

Klisyri Warnings/Precautions

Warnings/Precautions

Avoid eyes, periocular area, mouth, lips. Avoid use until skin is healed from any prior drug, procedure, or surgical treatment. Elderly. Pregnancy. Nursing mothers.

Klisyri Pharmacokinetics

See Literature

Klisyri Interactions

Not Applicable

Klisyri Adverse Reactions

Adverse Reactions

Local skin reactions, application site pruritus, application site pain.

Klisyri Clinical Trials

See Literature

Klisyri Note

Not Applicable

Klisyri Patient Counseling

See Literature

Images